JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB191568

Anti-MAGEA9 抗体 [EPR16258]

Anti-MAGEA9 antibody [EPR16258]

Be the first to review this product! Submit a review

|

(2 Publications)

Rabbit Recombinant Monoclonal MAGEA9 antibody. Suitable for IP, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 2 publications.

別名を表示する

MAGE9, MAGEA9A, MAGEA9B, MAGEA9, Melanoma-associated antigen 9, Cancer/testis antigen 1.9, MAGE-9 antigen, CT1.9

4 Images
Flow Cytometry (Intracellular) - Anti-MAGEA9 antibody [EPR16258] (AB191568)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-MAGEA9 antibody [EPR16258] (AB191568)

Intracellular flow cytometric analysis of 562 cells labeling MAGEA9 using ab191568 at 1/350 dilution (red) or rabbit monoclonal IgG as isotype control (green). Secondary antibody Goat anti rabbit IgG (FITC). Cells were fixed in 2% paraformaldehyde.

Immunoprecipitation - Anti-MAGEA9 antibody [EPR16258] (AB191568)
  • IP

Supplier Data

Immunoprecipitation - Anti-MAGEA9 antibody [EPR16258] (AB191568)

Immunoprecipitation analysis of human testis tissue lysate labeling MAGEA9 using ab191568 at 1/100 dilution (Left Lane). A Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1500 was used as secondary antibody. Right Lane : PBS instead of human testis tissue lysate.

All lanes:

Immunoprecipitation - Anti-MAGEA9 antibody [EPR16258] (ab191568)

Predicted band size: 35 kDa

false

Western blot - Anti-MAGEA9 antibody [EPR16258] (AB191568)
  • WB

Supplier Data

Western blot - Anti-MAGEA9 antibody [EPR16258] (AB191568)

5% NFDM/TBST blocking buffer

All lanes:

Western blot - Anti-MAGEA9 antibody [EPR16258] (ab191568) at 1/1000 dilution

Lane 1:

Human testis lysate at 10 µg

Lane 2:

Human melanoma lysate at 10 µg

Secondary

All lanes:

Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution

Predicted band size: 35 kDa

false

Western blot - Anti-MAGEA9 antibody [EPR16258] (AB191568)
  • WB

Supplier Data

Western blot - Anti-MAGEA9 antibody [EPR16258] (AB191568)

All lanes:

Western blot - Anti-MAGEA9 antibody [EPR16258] (ab191568) at 1/1000 dilution

All lanes:

K562 cell lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 35 kDa

false

関連する標識済み抗体及び組成の異なる製品 (1)

  • Carrier free

    Anti-MAGEA9 antibody [EPR16258] - BSA and Azide free

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR16258

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

WB, Flow Cyt (Intra), IP

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/100", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/350", "FlowCytIntra-species-notes": "<p><a href='/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" } } }

製品の詳細

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Conditional Ambient
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

MAGEA9 also known as Melanoma-associated antigen family A 9 is a protein encoded by the MAGEA9 gene. This protein has a molecular mass of approximately 36 kDa. MAGEA9 is mainly expressed in testis and certain tumors making it a cancer/testis (CT) antigen. The specificity of this expression pattern makes MAGEA9 a valuable target in cancer research especially for immunotherapy approaches.
Biological function summary

MAGEA9 functions as an element facilitating cellular processes like proliferation and apoptosis. Although MAGEA9 itself is not part of any known complex its expression can influence the regulatory mechanisms within cells supporting cellular survival and growth under oncogenic stress. It has roles in modifying the transcriptional activity affecting genes involved in cell cycle regulation.

Pathways

The involvement of MAGEA9 extends to the p53 pathway and the MAPK signaling pathway both critical for cell cycle and survival regulation. In the p53 pathway MAGEA9 can interfere with normal p53 function which is vital for DNA damage response and apoptosis. MAGEA9 may interact indirectly with proteins such as p21 a well-known downstream effector of p53 impacting the pathway's ability to manage cell cycle arrest and maintain genomic stability.

MAGEA9 holds significant relevance in cancers particularly melanoma and lung cancer. The aberrant expression of MAGEA9 in these diseases highlights its potential utility in diagnostic and therapeutic applications. MAGEA9 expression has been linked with poor prognosis due to its potential to alter pathways related to cell death and proliferation. In some contexts MAGEA9 possibly interacts with other proteins like MAGEA4 which may collectively contribute to oncogenesis and tumor progression.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Not known, though may play a role in embryonal development and tumor transformation or aspects of tumor progression.
See full target information MAGEA9

文献 (2)

Recent publications for all applications. Explore the full list and refine your search

International journal of molecular sciences 24: PubMed37629027

2023

Aerobic Exercise Facilitates the Nuclear Translocation of SREBP2 by Activating AKT/SEC24D to Contribute Cholesterol Homeostasis for Improving Cognition in APP/PS1 Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Zelin Hu,Yangqi Yuan,Zhen Tong,Meiqing Liao,Shunling Yuan,Weijia Wu,Yingzhe Tang,Yirong Wang,Changfa Tang,Wenfeng Liu

Journal of cellular biochemistry 120:1245-1257 PubMed30302801

2018

MiR-143-3p suppresses cell proliferation, migration, and invasion by targeting Melanoma-Associated Antigen A9 in laryngeal squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Liang Han,Mingming Tang,Xinjiang Xu,Bin Jiang,Yingze Wei,Hongyan Qian,Xueguan Lu
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com